BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 12/08/2026

Government Owned Invention Available for License: Monoclonal Antibody (RO4) That Reacts With the Juxta-Membrane Region of Mesothelin

The National Cancer Institute is seeking research co-development partners and/or licensees for a novel monoclonal antibody, RO4, which targets mesothelin-expressing cancers and could be used to treat these types of cancers.

Source: Federal Register — Health and Human ServicesOpen original release →